Gene therapists hopeful as trials resume with childhood disease.
Check
Erika
E
D048868:Adaptor Proteins, Signal Transducing; D002648:Child; D041321:Chromosomes, Human, X / Q000235:genetics; D002986:Clinical Trials as Topic / Q000009:adverse effects / Q000331:legislation & jurisprudence*; D004268:DNA-Binding Proteins / Q000235:genetics; D005602:France; D008040:Genetic Linkage / Q000235:genetics; D015316:Genetic Therapy / Q000009:adverse effects / Q000331:legislation & jurisprudence*; D006801:Humans; D007223:Infant; D060588:LIM Domain Proteins; D007938:Leukemia / Q000150:complications / Q000235:genetics; D008667:Metalloproteins / Q000235:genetics; D011518:Proto-Oncogene Proteins; D012306:Risk; D016511:Severe Combined Immunodeficiency / Q000150:complications / Q000235:genetics* / Q000628:therapy*; D014481:United States; D014486:United States Food and Drug Administration
D048868:Adaptor Proteins, Signal Transducing; D004268:DNA-Binding Proteins; D060588:LIM Domain Proteins; C085117:LMO2 protein, human; D008667:Metalloproteins; D011518:Proto-Oncogene Proteins